Related Experiment Videos
Bioprosthetic valve endocarditis: factors affecting bad outcome
C Gagliardi1, L Di Tommaso, P Mastroroberto
1Department of Cardiac Surgery, 2nd Medical School, University of Naples, Italy.
The Journal of Cardiovascular Surgery
|November 1, 1991
Summary
Prosthetic valve endocarditis (PVE) is a serious complication after valve replacement. Early PVE significantly increases mortality risk, highlighting the need for prompt treatment.
Area of Science:
- Cardiology
- Infectious Diseases
- Surgical Complications
Background:
- Prosthetic valve endocarditis (PVE) is a rare but severe complication following cardiac valve replacement surgery.
- Identifying predictive factors for poor outcomes in PVE patients is crucial for effective management.
Purpose of the Study:
- To analyze risk factors associated with prosthetic valve endocarditis (PVE).
- To identify predictors of adverse outcomes in patients with PVE.
Main Methods:
- Retrospective analysis of patients with prosthetic valve endocarditis (PVE).
- Evaluation of risk factors including timing of endocarditis (early vs. late), disease activity (active vs. healed), and presence of congestive heart failure or arterial emboli.
Main Results:
- Overall mortality rate for PVE was 46.8%.
- Early PVE (<0.01) demonstrated a significantly higher mortality rate (80%) compared to late PVE (38%).
- In reoperated patients, active endocarditis (70%) had higher mortality than healed endocarditis (28.5%) (p<0.05).
Conclusions:
- Early prosthetic valve endocarditis (PVE) is associated with a substantially worse prognosis.
- Combined medical and surgical management, including preoperative antibiotic therapy, is recommended for bioprosthetic valve endocarditis.